Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 2:11:1079601.
doi: 10.3389/fpubh.2023.1079601. eCollection 2023.

Undiagnosed diseases: Needs and opportunities in 20 countries participating in the Undiagnosed Diseases Network International

Affiliations

Undiagnosed diseases: Needs and opportunities in 20 countries participating in the Undiagnosed Diseases Network International

Domenica Taruscio et al. Front Public Health. .

Abstract

Introduction: Rare diseases (RD) are a health priority worldwide, overall affecting hundreds of millions of people globally. Early and accurate diagnosis is essential to support clinical care but remains challenging in many countries, especially the low- and medium-income ones. Hence, undiagnosed RD (URD) account for a significant portion of the overall RD burden.

Methods: In October 2020, the Developing Nations Working Group of the Undiagnosed Diseases Network International (DNWG-UDNI) launched a survey among its members, belonging to 20 countries across all continents, to map unmet needs and opportunities for patients with URD. The survey was based on questions with open answers and included eight different domains. Conflicting interpretations were resolved in contact with the partners involved.

Results: All members responded to the survey. The results indicated that the scientific and medical centers make substantial efforts to respond to the unmet needs of patients. In most countries, there is a high awareness of RD issues. Scarcity of resources was highlighted as a major problem, leading to reduced availability of diagnostic expertise and research. Serious equity in accessibility to services were highlighted both within and between participating countries. Regulatory problems, including securing informed consent, difficulties in sending DNA to foreign laboratories, protection of intellectual property, and conflicts of interest on the part of service providers, remain issues of concern. Finally, most respondents stressed the need to strengthen international cooperation in terms of data sharing, clinical research, and diagnostic expertise for URD patients in low and medium income countries.

Discussion: The survey highlighted that many countries experienced a discrepancy between the growing expertise and scientific value, the level of awareness and commitment on the part of relevant parties, and funding bodies. Country-tailored public health actions, including general syllabus of medical schools and of the education of other health professionals, are needed to reduce such gaps.

Keywords: Undiagnosed Diseases; data sharing; developing nations; rare diseases; survey.

PubMed Disclaimer

Conflict of interest statement

SW was employed by Rare Disease Ghana Initiative. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Countries participating to the Undiagnosed Rare Diseases Network International (purple), countries included in the Developing Nations Working Group (flag).
Figure 2
Figure 2
Unmet needs to tackle undiagnosed patients. X axis: percentage of response.
Figure 3
Figure 3
Health care organization for diagnosis of complex and rare diseases. Federated health care organization: Brazil, Georgia, Hungary, Italy, Singapore, Spain, Sweden. No organized healthcare system at all: DR Congo, Ecuador, Mexico, Pakistan. Centralized health care organization: Ghana, Mali, Philippines, Sri Lanka, Thailand. Hybrid (Federated and Centralized) health care organization: Australia, India, Turkey, USA.
Figure 4
Figure 4
Health care organization: Expert Centers for RD diagnosis.
Figure 5
Figure 5
Existence of regulations for data sharing with international. Outer circle: Regulations governing data sharing from the general population with international partners; Inner circle: Regulation governing data sharing from the indigenous populations.

References

    1. Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. . Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. (2020) 28:165–73. 10.1038/s41431-019-0508-0 - DOI - PMC - PubMed
    1. Regulation (EC) no 141/2000 of the European Parliament and of the Council of 16 December 1999 on Orphan Medicinal Products . Available online at: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32000R0141... (accessed October 18, 2022).
    1. Public Law 107-280 November 2002 . An act to amend the Public Health Service Act to establish an Office of Rare Diseases at the National Institutes of Health, and for other purposes. Available online at: https://www.govinfo.gov/app/details/PLAW-107publ280#:~:text=An%20act%20t...
    1. Hayashi S, Umeda T. 35 years of Japanese policy on rare diseases. The Lancet. (2008) 372: 889–90. 10.1016/S0140-6736(08)61393-8 - DOI - PubMed
    1. Anderson M, Elliott EJ, Zurynski YA. Australian families living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support. Orphanet J Rare Dis. (2013) 11:22. 10.1186/1750-1172-8-22 - DOI - PMC - PubMed

Publication types